Our funded projects include a study of interactions among genomics, aging and metabolism and a clinical trial of metformin and lifestyle modifications for reducing AF burden.
Understanding of atrial fibrillation (AF) risk factors and complications is based largely on studies that haven’t assessed AF burden. Our expert explains why that needs to change.
A new study identified genes and genetic variations associated with 12 loci linked to risk for atrial fibrillation. The result is a genome-wide catalog to facilitate follow-on investigations.
Cleveland Clinic researchers explain how they’ll use a new $3.1 million NHLBI grant to create and manipulate cardiac myocytes to better understand risk variants in genes linked to atrial fibrillation.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Percutaneous coronary intervention can now be considered in selected hemodynamically stable patients with multivessel disease. An expert from the guideline writing committee provides the backstory.